Pyroglutamic aciduria
Pyroglutamic Aciduria[edit | edit source]
Pyroglutamic aciduria, also known as 5-oxoprolinuria, is a rare metabolic disorder characterized by the excessive accumulation of pyroglutamic acid (5-oxoproline) in the urine. This condition is often associated with disruptions in the gamma-glutamyl cycle, which is crucial for the synthesis and degradation of glutathione, an important antioxidant in the body.
Pathophysiology[edit | edit source]
Pyroglutamic aciduria results from a defect in the gamma-glutamyl cycle, particularly involving the enzyme glutathione synthetase or, less commonly, 5-oxoprolinase. The gamma-glutamyl cycle is responsible for the synthesis and breakdown of glutathione, a tripeptide composed of glutamate, cysteine, and glycine. Disruptions in this cycle lead to the accumulation of pyroglutamic acid, a byproduct of glutathione metabolism.
Clinical Presentation[edit | edit source]
Patients with pyroglutamic aciduria may present with a variety of symptoms, which can range from mild to severe. Common symptoms include:
- Metabolic acidosis
- Neurological deficits
- Developmental delay
- Hemolytic anemia
The severity of symptoms often correlates with the degree of enzyme deficiency and the accumulation of pyroglutamic acid.
Diagnosis[edit | edit source]
Diagnosis of pyroglutamic aciduria is typically made through the detection of elevated levels of pyroglutamic acid in the urine using techniques such as gas chromatography-mass spectrometry (GC-MS). Additional tests may include blood tests to assess acid-base balance and genetic testing to identify mutations in the genes encoding enzymes of the gamma-glutamyl cycle.
Treatment[edit | edit source]
Treatment of pyroglutamic aciduria focuses on managing symptoms and preventing complications. This may include:
- Dietary modifications to reduce the intake of glutamine and glycine
- Supplementation with bicarbonate to correct metabolic acidosis
- Antioxidant therapy to support glutathione levels
In some cases, specific enzyme replacement therapies may be considered if available.
Prognosis[edit | edit source]
The prognosis for individuals with pyroglutamic aciduria varies depending on the severity of the enzyme deficiency and the effectiveness of treatment. Early diagnosis and intervention can improve outcomes and quality of life for affected individuals.
Research and Future Directions[edit | edit source]
Ongoing research into the genetic and biochemical mechanisms underlying pyroglutamic aciduria may lead to improved diagnostic methods and novel therapeutic approaches. Advances in gene therapy and enzyme replacement therapy hold promise for the future management of this rare disorder.
NIH genetic and rare disease info[edit source]
Pyroglutamic aciduria is a rare disease.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD